Two years of the Decentralized Trials and Research Alliance: an interview with Craig Lipset

Amplified by the COVID-19 pandemic, which dramatically hindered the progress of many clinical trials, and made possible by advances digital health technologies, decentralized clinical trials (DCTs) are a ‘hot topic’ in drug development, clinical studies and real-world research. DCTs not only foster better patient engagement and diversity in clinical trials, but they also allow the data captured to be more representative of patients’ experiences and needs in the ‘real-world’. To accelerate the broad adoption of DCTs and develop best practices, the Decentralized Trials and Research Alliance (DTRA) was formed in December 2020 by a wide range of stakeholders, including healthcare...